Condition

Chronic Insomnia: CBT-I, Medication, and Sleep Hygiene

Summary

Insomnia disorder affects an estimated 10% to 20% of adults, and about half of those cases follow a chronic course rather than resolving on their own. Clinical guidelines from the American College of Physicians and the American Academy of Sleep Medicine name cognitive behavioral therapy for insomnia (CBT-I) — not medication — as the first-line treatment, and meta-analyses show it helps people fall asleep faster and stay asleep, with gains that persist after treatment ends. Sleep hygiene advice on its own is not recommended as a standalone therapy.

Written by Gale Editorial · grounded in the cited clinical sources below · Updated 2026-07-07. How we write.

Talk to a clinician

Gale can match you with a clinician licensed in your state — the honest cost shown before you book.

Find care →

What chronic insomnia is

Everyone sleeps badly sometimes. Chronic insomnia disorder is different: it is regular difficulty falling asleep, staying asleep, or waking too early, together with daytime consequences — fatigue, low mood, irritability, difficulty concentrating — that continues over a sustained period rather than a single stressful week 5.

It is common. Insomnia disorder affects an estimated 10% to 20% of adults, and in roughly half of those cases the problem follows a chronic course rather than resolving on its own 5. Because sleep loss feeds daytime symptoms and daytime stress feeds sleeplessness, chronic insomnia tends to become self-sustaining — one reason brief fixes rarely hold.

Why sleep hygiene alone rarely fixes it

"Sleep hygiene" — a consistent bedtime, a dark and cool room, less caffeine and screen time before bed — is sound general advice, and it appears on nearly every list of sleep tips. As a standalone treatment for chronic insomnia, however, it does not have the evidence to support it. The American Academy of Sleep Medicine's 2021 clinical practice guideline explicitly suggests that clinicians not use sleep hygiene as a single-component therapy for chronic insomnia disorder 2.

The honest framing is that sleep hygiene is an adjunct, not a cure. It can remove obstacles to sleep, but on its own it does not retrain the conditioned wakefulness that keeps chronic insomnia going. The treatments that do carry strong evidence are the structured, active components described below.

CBT-I: the first-line treatment

Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment. The American College of Physicians recommends that all adult patients receive CBT-I as the initial treatment for chronic insomnia disorder — a strong recommendation — with medication considered only through shared decision-making if CBT-I alone is unsuccessful 1. The American Academy of Sleep Medicine likewise gives a strong recommendation for multicomponent CBT-I 2.

CBT-I is not a single technique but a package delivered over roughly four to eight sessions. Its core components include 2:

  • Stimulus control — rebuilding the association between bed and sleep, so the bed is used only for sleep and the person gets up when unable to sleep
  • Sleep restriction — temporarily limiting time in bed to consolidate sleep and rebuild the drive to sleep
  • Cognitive restructuring — addressing the anxious, catastrophic thinking about sleep that keeps the mind aroused
  • Relaxation techniques — lowering physiological arousal at bedtime

Stimulus control, sleep restriction, and relaxation each carry their own evidence as single-component therapies, but they are most often combined into the full CBT-I package 2.

How well CBT-I works

CBT-I has been tested in dozens of randomized trials. A 2015 systematic review and meta-analysis in Annals of Internal Medicine pooled 20 studies (1,162 participants) and found clinically meaningful improvements at the end of treatment: people fell asleep about 19 minutes faster (sleep onset latency), spent about 26 minutes less awake after first falling asleep (wake after sleep onset), and improved sleep efficiency — the share of time in bed actually spent asleep — by about 10 percentage points 3.

A feature that distinguishes CBT-I from sleeping pills is durability: in the meta-analysis, the gains appeared to be sustained at later follow-up, and no adverse effects were reported 3. Medication, by contrast, generally works only while it is being taken 1.

CBT-I online and by telehealth

Access to a trained CBT-I therapist has historically been the main barrier, and remote delivery narrows that gap. A meta-analysis of 11 randomized controlled trials (1,460 participants) found that internet-delivered CBT-I improved insomnia severity, sleep efficiency, sleep quality, time awake after sleep onset, sleep onset latency, and total sleep time, with effect sizes ranging from 0.21 to 1.09 and results generally maintained at follow-up out to nearly a year 6. The effects were comparable to face-to-face CBT-I, and longer programs that included some clinician support tended to work better 6.

Where medication fits

Prescription sleep medication is a second-line option, not a first step, and guidelines frame it as short-term and chosen through a discussion of benefits, harms, and cost 1. The American Academy of Sleep Medicine's pharmacologic guideline reviewed the common agents — including zolpidem, eszopiclone, zaleplon, temazepam, triazolam, ramelteon, doxepin, and suvorexant — and every individual medication recommendation was rated weak, reflecting limited certainty in the balance of benefits and harms 4.

Several widely used over-the-counter and supplement options were reviewed and not recommended for chronic insomnia, including diphenhydramine (the antihistamine in most OTC sleep aids), melatonin, valerian, and tryptophan 4. The same guideline also suggests not using trazodone — a prescription antidepressant sometimes used off-label for sleep — for chronic insomnia 4. This does not mean medication has no role — it means it generally works best paired with, or following, CBT-I rather than as a substitute for it.

What to expect when seeking care

Assessment usually begins with a clinical interview and a sleep diary — a one- to two-week record of bedtimes, wake times, and night-time awakenings — which is more reliable than memory for spotting patterns 1. A clinician also screens for conditions that masquerade as or worsen insomnia, such as obstructive sleep apnea, restless legs, depression, anxiety, chronic pain, and the effects of caffeine, alcohol, or medications.

CBT-I is delivered by psychologists, primary care clinicians, and other trained providers, and increasingly through structured digital programs 126. Because guidelines place CBT-I first, many care pathways now offer behavioral treatment before, or alongside, a prescription.

Example practice profiles

3 example practice profiles focus on insomnia →

Common questions

No. Occasional poor sleep is normal. Chronic insomnia disorder is regular difficulty falling or staying asleep, or waking too early, that persists over a sustained period and produces daytime consequences such as fatigue, low mood, or trouble concentrating. It affects an estimated 10% to 20% of adults, and about half of those cases follow a chronic course rather than resolving on their own.

CBT-I is cognitive behavioral therapy for insomnia, a structured treatment usually delivered over roughly four to eight sessions. Its core components are stimulus control (rebuilding the link between bed and sleep), sleep restriction (consolidating sleep by limiting time in bed), cognitive restructuring (addressing anxious thinking about sleep), and relaxation techniques. It is the treatment guidelines recommend before medication.

Guidelines from the American College of Physicians and the American Academy of Sleep Medicine recommend CBT-I as the first-line treatment and reserve medication for second-line, short-term use. A key difference is durability: in a meta-analysis, the improvements from CBT-I appeared to be sustained after treatment ended, whereas guidelines frame sleep medication as a short-term treatment.

Sleep hygiene — consistent bedtimes, a dark cool room, limiting caffeine and screens before bed — is reasonable general advice, but on its own it is not an effective treatment for chronic insomnia. The American Academy of Sleep Medicine's 2021 guideline suggests clinicians not use sleep hygiene as a single-component therapy. It is best understood as an adjunct, not a cure.

Yes. A meta-analysis of 11 randomized controlled trials found that internet-delivered CBT-I improved insomnia severity, sleep efficiency, sleep onset latency, and time awake at night, with effects comparable to in-person therapy and generally maintained at follow-up. Longer programs that included some clinician support tended to work better.

The American Academy of Sleep Medicine's pharmacologic guideline reviewed several common over-the-counter and supplement options — including diphenhydramine (the antihistamine in most OTC sleep aids), melatonin, valerian, and tryptophan — and did not recommend them for chronic insomnia. Prescription options exist, but every individual medication recommendation in that guideline was rated weak.

Evaluation is reasonable when insomnia persists over months and interferes with mood, concentration, or daytime functioning; when there is loud snoring, gasping, or pauses in breathing during sleep (which can indicate sleep apnea); when alcohol or sedatives are being used to fall asleep; or when daytime sleepiness makes driving or working unsafe. Insomnia alongside persistent low mood or thoughts of self-harm warrants prompt help — call or text 988.

Related conditions

Anxiety: Symptoms, Types, and Treatment · Depression: Signs, Causes, and Treatment

Specialties

Behavioral Health: What Therapists and Psychiatrists Treat

Talk to a clinician

Say what's going on in your own words. Gale finds a clinician licensed in your state and shows the real cost before you book.

Find care →

When to seek care

  • —Insomnia that persists for months and interferes with mood, concentration, or daytime functioning
  • —Loud snoring, gasping, or pauses in breathing during sleep — possible obstructive sleep apnea that needs evaluation
  • —Relying on alcohol, cannabis, or over-the-counter sedatives to fall asleep
  • —Excessive daytime sleepiness that makes driving or working unsafe
  • —Insomnia alongside persistent low mood, hopelessness, or thoughts of self-harm — call or text 988

If you are having thoughts of suicide or self-harm, call or text 988 (Suicide and Crisis Lifeline, available 24/7). For a medical emergency, call 911.

General health information, not medical advice. Synthetic demonstration content.

References

  1. 1.Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD (2016). Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. doi:10.7326/M15-2175 ✓ACP strong recommendation that all adult patients receive CBT-I as the initial treatment for chronic insomnia disorder; medication considered only via shared decision-making (benefits, harms, cost of short-term use) if CBT-I alone is unsuccessful
  2. 2.Edinger JD, Arnedt JT, Bertisch SM, et al. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.8986 ✓Strong recommendation for multicomponent CBT-I; conditional recommendation AGAINST sleep hygiene as a single-component therapy; stimulus control, sleep restriction, and relaxation each recommended as single-component therapies (conditional)
  3. 3.Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D (2015). Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Annals of Internal Medicine. doi:10.7326/M14-2841 ✓20 studies, 1,162 participants; sleep onset latency improved by ~19 minutes, wake after sleep onset by ~26 minutes, sleep efficiency by ~9.9 percentage points; gains sustained at later follow-up with no adverse effects reported
  4. 4.Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017). Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.6470 ✓All individual medication recommendations rated WEAK (zolpidem, eszopiclone, zaleplon, temazepam, triazolam, ramelteon, doxepin, suvorexant); diphenhydramine, melatonin, valerian, tryptophan, and trazodone not recommended for chronic insomnia
  5. 5.Buysse DJ (2013). Insomnia. JAMA. doi:10.1001/jama.2013.193 ✓Prevalence of insomnia disorder approximately 10% to 20% of adults, with approximately 50% having a chronic course; insomnia characterized by difficulty initiating or maintaining sleep with daytime consequences
  6. 6.Zachariae R, Lyby MS, Ritterband LM, O'Toole MS (2016). Efficacy of internet-delivered cognitive-behavioral therapy for insomnia — A systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews. doi:10.1016/j.smrv.2015.10.004 ✓11 RCTs, 1,460 participants; internet-delivered CBT-I improved insomnia severity, sleep efficiency, sleep quality, wake after sleep onset, sleep onset latency, and total sleep time (effect sizes 0.21–1.09); comparable to face-to-face CBT-I and generally maintained at 4–48 week follow-up

https://www.gale.care/conditions/insomnia · 6 sources. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to conditions